Live Cases, Studies and Testimony by Stent Manufacturers Expected to
Highlight and Explain Increasing Use of IVUS
- Witness Live Case Examples of Advanced Practices by Leading Interventionalists, Broadcast from Around the World. - Hear About Current and New Studies Designed to Clarify the Role of IVUS in Improving Stent Results. - See How Many of the Major Fixed Imaging and Stent Manufacturers
are Embracing IVUS.
SAN DIEGO, Oct. 22 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced today activities planned for the 2007 Transcatheter Cardiovascular Therapeutics (TCT) conference that will take place from October 20th to October 25th in Washington D.C.
Live Case Examples
TCT's live cases will highlight advanced practices in stenting as performed by leading interventionalists worldwide. The use of IVUS in bare metal and drug eluting stent procedures is increasing as the importance of accurate stent placement and proper stent expansion has attracted renewed attention in recent months. Volcano's phased array and new rotational IVUS systems are expected to be incorporated into many TCT live case procedures. Among the systems expected to be demonstrated is Volcano's new fully integrated IVUS system, the s5i, which can offer significant workflow and efficiency improvements.
New and current studies designed to clarify the role of IVUS in helping
to improve stenting outcomes will be highlighted at TCT 2007. Volcano will
announce sponsorship of a major study designed to examine the role of IVUS
in accurate sten
|SOURCE Volcano Corporation|
Copyright©2007 PR Newswire.
All rights reserved